Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats

Toxicology Mechanisms and Methods

Volumn 23, Issue 4, 2013, Pages 223-234

  Deepa, Balasubramaniam ^a   Anuradha, Carani Venkatraman ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Collagen; Diabetic nephropathy; GLUT 1; Linalool; Nephrin

Indexed keywords

COLLAGEN; GLUCOSE; GLUCOSE TRANSPORTER 1; HYDROXYPROLINE; LINALOOL; NEPHRIN; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL LOSS; CONTROLLED STUDY; CYTOPLASM; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN ANALYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; KIDNEY; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; KIDNEY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MONOTERPENES; PODOCYTES; RATS; RATS, WISTAR; STREPTOZOCIN;

RATTUS;

EID: 84879568129     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.743638     Document Type: Article

References (34)

1. Aaltonen P, Luimula P, Astro?m E, et al. (2001). Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 81:1185-90.
2. Bishop JS. (1970). Inability of insulin to activate liver glycogen transferase D phosphatase in the diabetic pancreatectomized dog. Biochim Biophys Acta 208:208-18.
3. Bollen S, Keppens S, Stalmans W. (1998). Specific features of glycogen metabolism in the liver. Biochem J 336:19-31.
4. Bouché C, Serdy S, Kahn CR, et al. (2004). The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev 25:807-30.
5. Brandstrup N, Kirk JE, Bruni C. (1957). The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 12:166-71.
6. Brosius FC, Heilg CW. (2005). Glucose transporters in diabetic nephropathy. Pediatr Nephrol 20:447-51.
7. Chomczynski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 62:156-9.
8. D'Agord Schaan B, Lacchini S, Bertoluci MC, et al. (2001). Increased renal GLUT1 abundance and urinary TGF-beta1 in streptozotocininduced diabetic rats: implications for the development of nephropathy complicating diabetes. Horm Metab Res 33:664-9.
9. de la Garza-Rodea AS, Knaa?n-Shanzer S, den Hartigh JD, et al. (2010). Anomer-equilibrated streptozotocin solution for the induction of experimental diabetes in mice (Mus musculus). J Am Assoc Lab Anim Sci 49:40-4.
10. Deepa B, Anuradha CV. (2011). Linalool a plant derived monoterpene alcohol rescues kidney from diabetes-induced nephropathic changes via blood glucose reduction. Diabetologia Croatica 40:121-37.
11. Fiske CH, Subbarow Y. (1925). The colorimetric determination of phosphorus. J Biol Chem 66:375-400.
12. Gancedo JM, Gancedo C. (1971). Fructose 1, 6-bisphophatase, phosphofructokinase and glucose 6-phosphate dehydrogenase from fermenting yeast and non-fermenting yeast. Arch Microbiol 76:132-8.
13. Greenberg CC, Jurczak MJ, Danos AM, et al. (2006). Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways. Am J Physiol Endocrinol Metab 291:1-8.
14. Greka A, Mundel P. (2012). Cell biology and pathology of podocytes. Annu Rev Physiol 74:299-323.
15. Heilig CW, Concepcion LA, Riser BL, et al. (1995). Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest S96:1802-14.
16. Khoshnoodi J, Tryggvason K. (2001). Unraveling the molecular make-up of the glomerular podocyte slit diaphragm. Exp Nephrol 9:355-9.
17. Koide H, Oda T. (1959). Pathological occurrence of glucose 6-phosphatase in serum in liver diseases. Clin Chim Acta 4:554-61.
18. Kubo I, Muroi H, Himejima M. (1992). Antimicrobial activity of green tea flavor components and their combination effects. J Agric Food Chem 40:245-8.
19. Moeller MJ, Soofi A, Hartmann I, et al. (2004). Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15:61-7.
20. Mora C, Navarro JF. (2005). The role of inflammation as a pathogenic factor in the development of renal disease in diabetes. Curr Diab Rep 5: 399-401.
21. Morales MA, Jabaggy AJ, Terenl HP. (1973). Mutations affecting accumulation of glycogen. Neurospora News Lett 20:24-5.
22. Nagai R, Unno Y, Hayashi MC, et al. (2002). Peroxynitrite induces formation of N (epsilon)-(carboxymethyl) lysine by the cleavage of amadori product and generation of glucosone and glyoxal fromglucose: novel pathways for protein modification by peroxynitrite. Diabetes 51:2833-9.
23. Parinandi NL, Thompson EDW, Schmid HOH. (1990). Diabetes heart and kidney exhibit increased resistance to lipid peroxidation. Biochim Biophys Acta 1047:63-9.
24. Peana AT, D'Aquila PS, Panin F, et al. (2002). Anti- inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 9:721-6.
25. Postic C, Shiota M, Magnuson MA. (2001). Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res 56:195-217.
26. Rifkin H, Porte D, eds. (1990). Ellenbery and Rifkin's diabetes mellitus: theory and practice. 4th ed. New York: Elsevier.
27. Said-Al Ahl HAH, Mahmoud AA. (2010). Effect of zinc and/or iron foliar application on growth and essential oil of sweet basil (Ocimum basilicum L.) under salt stress. Ozean J Appl Sci 3:97-111.
28. Sego S. (2007). Pathophysiology of diabetic nephropathy. Nephrol Nurs J 34:631-3.
29. Shull KH, Ashmore J, Mayer J. (1956). Hexokinase, glucose-6- phosphatase and phosphorylase levels in hereditarily obese-hyperglycemic mice. Arch Biochem Biophy 62:210-16.
30. Takano Y, Yamauchi K, Hayakawa K, et al. (2007). Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett 581: 421-6.
31. Tarnow L, Rossing P, Nielsen FS, et al. (2000). Cardiovascular morbidity and early mortality cluster in patients of type1 diabetic patients with diabetic nephropathy. Diabetes Care 23:30-3.
32. Wang ZP, Cai SX, Liu DB, et al. (2006). Anti-inflammatory effects of a novel peptide designed to bind with NF-kappaB p50 subunit. Acta Pharmacol Sin 27:1474-8.
33. Woessner JF. (1961). The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440-7.
34. Zafar M, Naeem-ul-Hassan Naqvi S. (2010). Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 28:135-42.